Thomas J Paulson - Net Worth and Insider Trading
Thomas J Paulson Net Worth
The estimated net worth of Thomas J Paulson is at least $6 dollars as of 2024-04-24. Thomas J Paulson is the CFO of NovaBay Pharmaceuticals Inc and owns about 78 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $6. Details can be seen in Thomas J Paulson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas J Paulson has not made any transactions after 2014-12-12 and currently still holds the listed stock(s).
Transaction Summary of Thomas J Paulson
Thomas J Paulson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas J Paulson owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .
Click here to see the complete history of Thomas J Paulson’s form 4 insider trades.
Insider Ownership Summary of Thomas J Paulson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2014-12-12 | Chief Financial Officer |
Thomas J Paulson Latest Holdings Summary
Thomas J Paulson currently owns a total of 1 stock. Thomas J Paulson owns 78 shares of NovaBay Pharmaceuticals Inc (NBY) as of December 12, 2014, with a value of $6.
Latest Holdings of Thomas J Paulson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2014-12-12 | 78 | 0.08 | 6 |
Holding Weightings of Thomas J Paulson
Thomas J Paulson Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas J Paulson has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 11 shares on December 12, 2014, which cost Thomas J Paulson around $6,800.
Insider Trading History of Thomas J Paulson
- 1
Thomas J Paulson Trading Performance
GuruFocus tracks the stock performance after each of Thomas J Paulson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas J Paulson is 1.6%. GuruFocus also compares Thomas J Paulson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas J Paulson within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas J Paulson's insider trading performs compared to the benchmark.
Performance of Thomas J Paulson
Average Return
-10.64%
Outperforming Transactions
60%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.12 | 1.6 | 34.37 | -10.64 | -20.71 | -28.27 |
| Relative Return to S&P 500(%) | 2.76 | -2.04 | 25.53 | -25.33 | -35.06 | -42.1 |
Thomas J Paulson Ownership Network
Ownership Network List of Thomas J Paulson
Ownership Network Relation of Thomas J Paulson
Thomas J Paulson Owned Company Details
What does NovaBay Pharmaceuticals Inc do?
Who are the key executives at NovaBay Pharmaceuticals Inc?
Thomas J Paulson is the Chief Financial Officer of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .
NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary
Over the past 18 months, Thomas J Paulson made no insider transaction in NovaBay Pharmaceuticals Inc (NBY). Other recent insider transactions involving NovaBay Pharmaceuticals Inc (NBY) include a net sale of 11,921 shares made by Audrey Kunin , and a net sale of 11,921 shares made by Jeffrey Kunin .
In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 23,842 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,842 shares.
NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovaBay Pharmaceuticals Inc Insider Transactions
Thomas J Paulson Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas J Paulson. Currently GuruFocus does not have mailing address information for Thomas J Paulson.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
